TNNI3 Antibody

• Gene Name:

  Troponin I, cardiac muscle

• Gene Aliases:

  CMH7, RCM1, cTnI, CMD2A, TNNC1, CMD1FF

• Gene ID:

  7137

• Swiss Prot:

  P19429

• Accession Number:

  NP_000354.4

• Reactivity:

  Human

• Immunogen:

  Purified human cardiac troponin I.

• Target:

  Monoclonal Mouse Anti-Human Cardiac Troponin I

• Clonality:

  Monoclonal

• Clone:

  2D5

• Type:

  Monoclonal Antibody

• Applications:

  WB, IHC, IP

• Assay Protocol:

  Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol

• Format:

  Concentrated

• Reconstitution:

  Store at 2 - 8C for short term, freeze under -20C for long term storage.

• Molecular Weight:

  21 kD

• Fragment:

  IgG1kappa

• Specificity:

  This antibody is specific for human cardiac troponin subunit I, a 21 kD protein responsible for inhibiting actomyosin Mg2+-ATPase activity. This antibody has less than 0.1% reactivity with human skeletal TNI as measured by ELISA.

• NCBI Gene Symbol:

  TNNI3

• Host or Source:

  Mouse

• Protein Name:

  Troponin I, cardiac muscle

• Gene Name URL:

  TNNI3

• CAS Number:

  9007-83-4

• Nucleotide Accession Number:

  NM_000363.4